Mycostatin

"The U.S. Food and Drug Administration announced today that injectable drugs used in total parenteral nutrition (TPN) in critical shortage will be imported into the United States and available to patients this week.

Mycostatin

SIDE EFFECTS

The frequency of adverse events reported in patients using Mycostatin (nystatin) ®
preparations is less than 0.1%. The more common events that were reported include
allergic reactions, burning, itching, rash, eczema, and pain on application.
(See PRECAUTIONS: General.)